Chester B. Whitley

7.8k citations

201 papers · 5.1k indexed · h-index 39

Physiology top 0.5%
- Lysosomal Storage Disorders Research 142
Clinical Biochemistry top 0.5%
Rheumatology top 1%
- Glycogen Storage Diseases and Myoclonus 40
Cell Biology top 2%
- Cellular transport and secretion 16
Physiology top 1%
- Lysosomal Storage Disorders Research 142
Epidemiology
- Trypanosoma species research and implications 36
Pathology and Forensic Medicine
- Biomedical Research and Pathophysiology 18
Molecular Biology
- CRISPR and Genetic Engineering 18
Genetics
- Virus-based gene therapy research 16
- Neurogenetic and Muscular Disorders Research 14

Co-authors: Elsa Shapiro Paul Harmatz Li Ou Elena L. Aronovich R. Scott McIvor Dao Pan Robert J. Gorlin Elizabeth Braunlin
Cited by: Physiology Clinical Biochemistry Rheumatology
Journals: The Lancet (1 paper)Annals of Internal Medicine (2 papers)PLoS ONE (1 paper)
Partner nations: United States United Kingdom France

In The Last Decade

Chester B. Whitley

197 papers receiving 5.0k citations

Peers

Countries citing papers authored by Chester B. Whitley

Since Specialization

Citations

This map shows the geographic impact of Chester B. Whitley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chester B. Whitley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chester B. Whitley more than expected).

Fields of papers citing papers by Chester B. Whitley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chester B. Whitley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chester B. Whitley. The network helps show where Chester B. Whitley may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Chester B. Whitley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Chester B. Whitley Line = papers co-authored together Chester B. Whitley links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Bone marrow transplantation reverses metabolic alterations in multiple sulfatase deficiency: a case series Communications Medicine ·Nishitha R. Pillai,Ning Liu,Xiyuan Li,Xiqi Li,Rebecca C. Ahrens‐Nicklas,Laura Adang,Julie B. Eisengart,Grace Bronken,Ashish Gupta,Troy C. Lund,Chester B. Whitley,Sarah H. Elsea,Paul J. Orchard	2025	0
2	Dose-intensive therapy (DIT) for infantile Pompe disease: A pilot study Molecular Genetics and Metabolism Reports ·Jeanine R. Jarnes,Nishitha R. Pillai,Alia Ahmed,Sofia Shrestha,Michael J. Stark,Chester B. Whitley	2024	0
3	Intrathecal or intravenous AAV9-IDUA/RGX-111 at minimal effective dose prevents cardiac, skeletal and neurologic manifestations of murine MPS I Molecular Therapy — Methods & Clinical Development ·Lalitha R. Belur,Avery Huber,Hillary Mantone,Mason Robertson,Miles C. Smith,Andrea D. Karlen,Kelley F. Kitto,Ou Li,Chester B. Whitley,Elizabeth Braunlin,Justin W. Furcich,Troy C. Lund,Davis Seelig,Carolyn A. Fairbanks,Nicholas Buss,Kwi Hye Kim,R. Scott McIvor	2024	0
4	Disparities in late and lost: Pediatricians' role in following Pompe disease identified by newborn screening Molecular Genetics and Metabolism ·Nishitha R. Pillai,Noelle Andrea V. Fabie,Tory Kaye,Sondra D. Rosendahl,Alia Ahmed,Amy Hietala,Alissa Jorgenson,Brendan C. Lanpher,Chester B. Whitley	2023	2
5	Persistent bone and joint disease despite current treatments for mucopolysaccharidosis types I, II, and VI: Data from a 10‐year prospective study Journal of Inherited Metabolic Disease ·Bradley S. Miller,Ellen B. Fung,Klane K. White,Troy C. Lund,Paul Harmatz,Paul J. Orchard,Chester B. Whitley,Lynda E. Polgreen	2023	5
6	Sanfilippo syndrome: consensus guidelines for clinical care Orphanet Journal of Rare Diseases ·Nicole Muschol,Roberto Giugliani,Simon Jones,Joseph Muenzer,Nicholas Smith,Chester B. Whitley,Megan Donnell,Elise Drake,Kristina L. Elvidge,Lisa Melton,Cara O’Neill,(unknown)	2022	18
7	Agalsidase-Beta Therapy for Advanced Fabry Disease Annals of Internal Medicine ·Maryam Banikazemi,Jan Bultas,Stephen Waldek,William R. Wilcox,Chester B. Whitley,Timothy J. McDonald,Richard S. Finkel,Seymour Packman,Daniel G. Bichet,David G. Warnock,Robert J. Desnick	2020	1
8	Genotype‐phenotype relationships in mucopolysaccharidosis type I (MPS I): Insights from the International MPS I Registry Clinical Genetics ·L. Clarke,Roberto Giugliani,Nathalie Guffon,Simon Jones,Hillary A. Keenan,María Verónica Muñoz‐Rojas,Torayuki Okuyama,David Viskochil,Chester B. Whitley,Frits A. Wijburg,Joseph Muenzer	2019	51
9	Beneath the floor: re-analysis of neurodevelopmental outcomes in untreated Hurler syndrome Orphanet Journal of Rare Diseases ·Elsa Shapiro,Chester B. Whitley,Julie B. Eisengart	2018	18
10	Observational Prospective Natural History of Patients with Sanfilippo Syndrome Type B The Journal of Pediatrics ·Chester B. Whitley,Maureen Cleary,Eugen Mengel,Paul Harmatz,Elsa Shapiro,Igor Nestrašil,Patrick Haslett,David Whiteman,David Alexanderian	2018	25
11	Long-term outcomes of systemic therapies for Hurler syndrome: an international multicenter comparison Genetics in Medicine ·Julie B. Eisengart,Kyle Rudser,Yong Xue,Paul J. Orchard,Weston P. Miller,Troy C. Lund,Ans van der Ploeg,Jean Mercer,Simon Jones,Eugen Mengel,Seyfullah Gökce,Nathalie Guffon,Roberto Giugliani,Carolina Fishinger Moura de Souza,Elsa Shapiro,Chester B. Whitley	2018	43
12	Anesthetic care and perioperative complications in children with Sanfilipo Syndrome Type A Pediatric Anesthesia ·Elif C. Cingi,David S. Beebe,Chester B. Whitley,Kumar G. Belani	2016	8
13	Gene therapy for neurologic manifestations of mucopolysaccharidoses Expert Opinion on Drug Delivery ·Daniel Wolf,Sharbani Banerjee,Perry B. Hackett,Chester B. Whitley,R. Scott McIvor,Walter C. Low	2014	35
14	Neurocognitive and neuropsychiatric phenotypes associated with the mutation L238Q of the α-L-iduronidase gene in Hurler–Scheie syndrome Molecular Genetics and Metabolism ·Alia Ahmed,Chester B. Whitley,Renee Cooksley,Kyle Rudser,Stephanie Cagle,Nadia Ali,Kathleen Delaney,Brianna Yund,Elsa Shapiro	2013	24
15	Enzyme replacement therapy for mucopolysaccharidosis VI: Growth and pubertal development in patients treated with recombinant human N-acetylgalactosamine 4-sulfatase Journal of Pediatric Rehabilitation Medicine ·Celeste Decker,Zi‐Fan Yu,Roberto Giugliani,Ida Vanessa Döederlein Schwartz,Nathalie Guffon,Elisa Leão Teles,Clara Sá-Miranda,J. E. Wraith,Michael Beck,Laila Arash,Maurizio Scarpa,David Ketteridge,John J. Hopwood,Barbara Plecko,Robert D. Steiner,Chester B. Whitley,Paige Kaplan,Stuart J. Swiedler,Susan E. Conrad,Paul Harmatz	2010	52
16	Safety and efficacy of enzyme replacement therapy in combination with hematopoietic stem cell transplantation in Hurler syndrome Genetics in Medicine ·Satkiran S. Grewal,Robert Wynn,José E. Abdenur,Barbara K. Burton,Maged I. Gharib,Claudia M. Haase,Robert J. Hayashi,Shalini Shenoy,David Sillence,George E. Tiller,Martha Dudek,Annet van Royen‐Kerkhof,J. E. Wraith,Paul Woodard,Guy Young,Nico Wulffraat,Chester B. Whitley,Charles Peters	2005	74
17	Canine Heparan Sulfate Sulfamidase and the Molecular Pathology Underlying Sanfilippo Syndrome Type A in Dachshunds Genomics ·Elena L. Aronovich,K. Paige Carmichael,Hiroki Morizono,Ioannis G. Koutlas,Minerva Deanching,George Hoganson,Andrea Fischer,Chester B. Whitley	2000	20
18	Combined Ultrafiltration-Transduction in a Hollow-Fiber Bioreactor Facilitates Retrovirus-Mediated Gene Transfer into Peripheral Blood Lymphocytes from Patients with Mucopolysaccharidosis Type II Human Gene Therapy ·Dao Pan,Raji A. Shankar,David F. Stroncek,Chester B. Whitley	1999	9
19	Mobilization and Transduction of Peripheral Blood Progenitor Cells in Patients with Mucopolysaccharidosis I Journal of Hematotherapy ·Allison Hubel,David Stroncek,Dao Pan,Chester B. Whitley,Jeffrey McCullough	1998	1
20	Retroviral-Mediated Transfer of the Iduronate-2-Sulfatase Gene into Lymphocytes for Treatment of Mild Hunter Syndrome (Mucopolysaccharidosis Type II). University of Minnesota Medical School, Minneapolis, Minnesota Human Gene Therapy ·Chester B. Whitley,R. Scott McIvor,Elena L. Aronovich,Susan A. Berry,Bruce R. Blazar,Scott R. Burger,John H. Kersey,Richard A. King,Anthony J. Faras,Richard E. Latchaw,Jeffrey McCullough,Dao Pan,Norma K.C. Ramsay,David F. Stroncek	1996	27

About Chester B. Whitley

Chester B. Whitley is a scholar working on Physiology, Rheumatology and Physiology, having authored 201 papers that have together received 5.1k indexed citations. Recurring topics across this work include Lysosomal Storage Disorders Research (142 papers), Glycogen Storage Diseases and Myoclonus (40 papers), Trypanosoma species research and implications (36 papers), Biomedical Research and Pathophysiology (18 papers), CRISPR and Genetic Engineering (18 papers), Virus-based gene therapy research (16 papers), Cellular transport and secretion (16 papers) and Neurogenetic and Muscular Disorders Research (14 papers). The work is most often cited by research in Physiology (3.5k citations), Clinical Biochemistry (555 citations) and Rheumatology (908 citations). Chester B. Whitley has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Elsa Shapiro, Paul Harmatz, Li Ou, Elena L. Aronovich, R. Scott McIvor, Dao Pan, Robert J. Gorlin, Elizabeth Braunlin, Roland Günther and Brenda Koniar. Their work appears in journals such as The Lancet, Annals of Internal Medicine and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact